Literature DB >> 35082880

Chronic Toxoplasma gondii Infection Potentiates Parkinson's Disease Course in Mice Model.

Nima Firouzeh1,2, Naser Ziaali1,3, Vahid Sheibani4, Amir Hossein Doustimotlagh5, Ali Afgar6, Maryam Zamanpour7, Hossein Keshavarz8, Saeideh Shojaee8, Reza Shafiei2, Khadijeh Esmaeilpour4, Zahra Babaei9.   

Abstract

BACKGROUND: Toxoplasma gondii is a neuroinvasive protozoa pathogen that could manipulate its intermediate host's behavior. However, the possible link between T. gondii infection and the development of neurodegenerative disorders such as Parkinson's disease (PD) has been proposed, we tested the hypothesis that in chronic toxoplasmosis neuroinflammation, and molecular mediators potentiate behavioral-cognitive impairments in BALB/c mice with PD.
METHODS: To establish chronic toxoplasmosis by Tehran strain, cysts of T. gondii were injected intraperitoneally into BALB/c mice in Kerman, Iran in 2019. To induce the PD model, mice (BALB/c) were treated with Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The behavioral experiments such as anxiety and motor coordination were performed using the Open field and Rotarod tests. Additionally, we investigated the contribution of Toxoplasma-induced neuroinflammation, and behavioral-cognitive impairments in the PD mice model.
RESULTS: Chronic toxoplasmosis caused PD-like symptoms and induced various behavioral changes in infected BALB/c mice. In T. gondii infected+MPTP treated group, T. gondii infection could potentiate PD in infected mice receiving MPTP and caused remarkable dysfunction in motor coordination and change in anxiety and depression-like behaviors similar or more severe than PD group.
CONCLUSION: Chronic T. gondii infection exacerbates pathological progression of PD in BALB/c mice brain by promoting neuroinflammation, and behavioral changes establishing.
Copyright © 2021 Firouzeh et al. Published by Tehran University of Medical Sciences.

Entities:  

Keywords:  Anxiety behaviors, Parkinson; Behavioral impairments; Inflammation; Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); Toxoplasma gondii

Year:  2021        PMID: 35082880      PMCID: PMC8710207          DOI: 10.18502/ijpa.v16i4.7863

Source DB:  PubMed          Journal:  Iran J Parasitol        ISSN: 1735-7020            Impact factor:   1.012


  33 in total

1.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

2.  Protocol for the MPTP mouse model of Parkinson's disease.

Authors:  Vernice Jackson-Lewis; Serge Przedborski
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Impaired social behaviour and molecular mediators of associated neural circuits during chronic Toxoplasma gondii infection in female mice.

Authors:  Shiraz Tyebji; Simona Seizova; Alexandra L Garnham; Anthony J Hannan; Christopher J Tonkin
Journal:  Brain Behav Immun       Date:  2019-02-23       Impact factor: 7.217

4.  Erythropoietin ameliorates harmaline-induced essential tremor and cognition disturbances.

Authors:  Fatemeh Mohammadi; Mohsen Abedini Esfahlani; Mohammad Shabani
Journal:  Neurosci Lett       Date:  2019-04-08       Impact factor: 3.046

5.  Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1.

Authors:  Motamed Elsayed Mahmoud; Fumiki Ui; Doaa Salman; Maki Nishimura; Yoshifumi Nishikawa
Journal:  Cell Microbiol       Date:  2015-02-23       Impact factor: 3.715

6.  Nitric oxide production increases during Toxoplasma gondii encephalitis in mice.

Authors:  Gungor Cagdas Dincel; Hasan Tarik Atmaca
Journal:  Exp Parasitol       Date:  2015-06-24       Impact factor: 2.011

7.  Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice.

Authors:  Shih-jei Tsai; Che-yi Chao; Mei-chin Yin
Journal:  Eur J Pharmacol       Date:  2011-09-29       Impact factor: 4.432

Review 8.  Immune response and immunopathology during toxoplasmosis.

Authors:  Christopher D Dupont; David A Christian; Christopher A Hunter
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

9.  Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.

Authors:  Robert A Charvat; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

10.  Nanosilver Colloid Inhibits Toxoplasma gondii Tachyzoites and Bradyzoites in Vitro.

Authors:  Saeedeh Shojaee; Nima Firouzeh; Hussein Keshavarz; Sanaz Jafar-Pour Azami; Mahboobeh Salimi; Mehdi Mohebali
Journal:  Iran J Parasitol       Date:  2019 Jul-Sep       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.